Insecticides (India) Limited Q2 FY27 Revenue Rises 8% to ₹686 Crore

Insecticides (India) Limited reported Q2 FY27 revenue of ₹686.31 crore for July-September 2026, an 8% increase year-on-year, while consolidated net profit declined 5% to ₹56.17 crore. The result shows sales growth despite a reported 6-7% decline in volume, with premium-product sales supporting value growth.

What did Insecticides India report for Q2 FY27?

Insecticides India announced its Q2 and H1 FY27 results on 5 November 2026, reporting consolidated revenue from operations of ₹686.31 crore for the September quarter. Revenue was ₹637.70 crore in Q2 FY26, translating into a year-on-year increase of 7.62%, or about 8%.

The company reported profit after tax of ₹56.17 crore, compared with ₹59.11 crore a year earlier. This represented a 4.97% year-on-year decline in net profit despite the rise in revenue. The quarterly summary also cited a 13% margin, while EBITDA stood at ₹92.44 crore.

How did sales volumes and product mix shape the quarter?

Management said volume declined by 6-7% in Q2 FY27, but premium-product selling supported 4-5% value growth. This indicates that the higher-value product mix helped offset part of the effect of lower volumes on revenue during the quarter.

The available earnings-call summary does not provide a product-wise revenue split or identify specific products behind the premium-product contribution. It does, however, show that sales growth was driven by value rather than volume expansion. For an agrochemical company, this distinction is relevant because quarterly demand can be affected by farming activity, product mix and regional buying patterns.

What do Insecticides India's quarterly financial figures show?

Insecticides India's revenue grew faster than its operating profit, while net profit moved lower year-on-year. EBITDA increased 3.31% to ₹92.44 crore from ₹89.48 crore, trailing the 7.62% growth in revenue. The difference between sales and profit growth is the main financial feature of the reported quarter.

The results were discussed in an earnings conference call held at 5:00 pm IST on 5 November 2026. The call lasted about 52 minutes and included 26 questions from five analysts, according to the available call listing. The company also made the audio recording of its Q2 and H1 FY27 earnings call available online.

Why does the Q2 FY27 result matter for investors?

The quarter presents a mixed operating picture for investors. Revenue growth of about 8% shows that Insecticides India increased its sales value from the year-earlier period. But the decline in volume and the fall in profit after tax show that higher revenue did not translate into higher bottom-line earnings in the quarter.

The gap between EBITDA growth and revenue growth is also important. EBITDA rose by ₹2.96 crore year-on-year, while revenue rose by ₹48.61 crore. The reported 13% margin provides an operating-profitability reference point, though the supplied information does not provide a comparable margin figure for Q2 FY26.

No stock-price movement, valuation data or management earnings outlook was provided in the available material. As a result, the reported financial numbers offer the clearest basis for assessing the quarter: revenue improved, but volumes and net profit were lower than the corresponding period of FY26.

How does the result affect the agrochemical business outlook?

Insecticides India operates in the agrochemical sector, where quarterly sales can depend on crop cycles, product adoption and demand conditions across agricultural markets. The company's reported volume decline in Q2 FY27 highlights that sales value and physical volumes did not move in the same direction during the period.

The stated premium-product contribution shows the role of portfolio mix in supporting revenue when volumes are under pressure. However, the available information does not disclose whether the volume decline was concentrated in particular regions, crops or product categories. It also does not provide management guidance for subsequent quarters.

For customers and distribution partners, the result confirms continuing product sales during the quarter, with premium offerings contributing to value growth. For investors, the next relevant disclosures will be updates on volume trends, profitability and whether the company can sustain revenue growth while improving earnings conversion.

Conclusion

Insecticides India delivered Q2 FY27 consolidated revenue of ₹686.31 crore, up 7.62% year-on-year, but profit after tax declined 4.97% to ₹56.17 crore. Lower volumes were partly offset by premium-product sales, while EBITDA growth remained below revenue growth.

Investors will watch future company disclosures for changes in sales volumes, product mix, EBITDA performance and net-profit growth. The supplied material does not include formal guidance or a specific target for the next quarter, leaving subsequent results and management commentary as the key reference points.